Search for:

Record new drug approvals: ‘fleeting success’ or here to stay?

With a record 59 new drugs approved by the FDA and 42 new active substances recommended for authorization by the European Medicines Agency, 2018 was a profoundly productive year for biopharma. In a new analysis, Jamie Munro and Helen Dowden from Clarivate Analytics examine whether 2018 represents “a fleeting success” or if there are underlying […]

Record new drug approvals: ‘fleeting success’ or here to stay?

With a record 59 new drugs approved by the FDA and 42 new active substances recommended for authorization by the European Medicines Agency, 2018 was a profoundly productive year for biopharma. In a new analysis, Jamie Munro and Helen Dowden, of Clarivate Analytics, examine whether 2018 represents “a fleeting success” or if there are underlying changes […]

Brand infringement – Learn how to protect your trademark portfolio

Policing trademarks has never been more difficult. Globalization and the proliferation of online commercial channels means it’s harder than ever to find and register a unique mark. In addition, with the ubiquity of social media and advancements in marketing technology, it’s also much easier for businesses to create and promote brands in amazing new ways. […]

We’re supporting open access in the DACH region – here’s how

The Web of Science is accelerating scientific exchange and progress in Germany, Austria and Switzerland by providing key publication data to Germany’s Open Access Monitor.   The Web of Science™, part of Clarivate™, has long been an advocate for open access content. Our publisher-neutral data helps the research community discover and evaluate high-quality open access […]

Easing the Path to Access OA Content for Researchers – Part 1

This week marks the 10th anniversary of ‘International Open Access Week,’ and this year’s observance carries a thought-provoking theme: “Open in order to….” This is in itself an open-ended statement which urges us all to focus on what Open Access (OA) really enables, and how we can further enable OA. Clarivate Analytics is not a […]

Despite solid API market growth, India and China face challenges – including around costs

Companies have chosen India as a sourcing destination for many years due to India’s lower cost structure for manufacturing, labor, materials and equipment. India possesses a large talent pool of chemical engineers and scientists and a large manufacturing capacity focused on regulated markets.  China also has a talented pool of scientists and engineers, a low […]